sharecast

{{ storiesRelated.title }}

Regulatory News
02 Sep, 2024 07:00 02 Sep, 2024 07:01

Result of Meeting

RNS Number : 4093C
Flex Labs Inc.
02 September 2024
 

2 September 2024

 

 

 

Flex Labs Inc

 

("Flex" or the "Company")

 

Results of Meeting

 

Flex Labs Inc (AQSE: FLEX) announces that all resolutions were duly passed at the Company's Special Meeting held on 30 August 2024.

 

For further information, visit: https://www.flexlabs.ai

 

The directors of Flex accept responsibility for this announcement.

 

For further information please contact:

 

Flex Labs Inc

Michael Edwards 

Via First Sentinel 

 

First Sentinel (Corporate Adviser) 

Brian Stockbridge 

  

[email protected]  

 

+44 (0) 20 3855 5551

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXQKKBNFBKDDFN